Pharmidex
Dr. Saurabh Jain is a Senior Scientist at Pharmidex since January 2021, specializing in respiratory and oncology studies. Previously, as a Post Doctoral Associate at the University of Sheffield from November 2014 to January 2021, Dr. Jain developed a vaccine targeting stroke, conducting both in-vivo and in-vitro testing. Early research experience includes an MSc project at Oncimmune focused on identifying immunogenic regions of tumor-associated antigens, as well as training in Medical Microbiology at JJ Hospital in Mumbai. Dr. Jain holds a PhD in Development of Biologics from the University of Edinburgh and an MSc in Cancer Immunotherapy from the University of Nottingham, in addition to a BSc in Biotechnology from Bhavans College.
This person is not in any teams
This person is not in any offices
Pharmidex
Pharmidex is an AAALAC-accredited, UK-based CRO founded in 2002. We provide high-quality, cost-effective, flexible and rapid solutions in drug metabolism and pharmacokinetics (DMPK), bioanalysis (non-GLP/GLP/GCP), toxicology (non-GLP/GLP), histology, clinical chemistry, hematology, and in vitro ADME. Pharmidex also offers in silico modelling and efficacy models supporting oncology, CNS, respiratory, stroke, autoimmune, and metabolic disease programs. We work with over 250 global clients, including medical charities, academic groups, biotech, and pharma, and have undertaken over 15,000 studies. In addition to our fee-for-service offering, Pharmidex actively seeks collaboration opportunities in grant-funded projects. To date, we have successfully participated in over 30 collaborative grant-funded projects, partnering with more than 167 global collaborators.